Nisoldipine attenuates myocardial stunning induced by multiple coronary occlusions in conscious pigs and this effect is independent of changes in hemodynamics or coronary blood flow

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 4, 1996, Pages 655-666

  Park, Seong Wook ^a   Tang, Xian Liang ^a,b   Qiu, Yumin ^a,b   Sun, Jian Zhong ^a   Bolli, Roberto ^a,b  

^a Department of Medicine   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

Calcium channel blockers; Myocardial stunning; Nisoldipine; Pig; Post ischemic dysfunction; Repetitive ischemia

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; NISOLDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; STUNNED HEART MUSCLE; SWINE;

EID: 0029985544     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0061     Document Type: Article

References (62)

1. BECKER LC, LEVINE JH, DIPAULA AF, GUARNIERI T, AVERSANO TR, 1986. Reversal of dysfunction in postischemic stunned myocardium by epinephrine and post-extrasystolic potentiation. J Am Coll Cardial 7: 580-589.
2. BLOOR CM, WHITE FC, LAMMERS RJ, 1986. Cardiac ischemia and coronary blood flow in swine. In: Stanton HC, Mersmann HJ, eds, Swine in Cardiovascular Research. Boca Raton, Florida. CRC Press, 87-97.
3. BOLLI R, 1990. Mechanism of myocardial "stunning". Circulation 82: 723-738.
4. BOLLI R, 1992. Myocardial "stunning" in man. Circulation 86: 1671-1691.
5. BOLLI R, MYERS ML, ZHU WX, ROBERTS R, 1986. Disparity of reperfusion arrhythmias after reversible myocardial ischemia in open chest and conscious dogs. J Am Coll Cardial 5: 1047-1056.
6. BOLLI R, PATEL BS, JEROUDI MO, LAI EK, MCCAY PB, 1988a. Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest 82: 476-485.
7. BOLLI R, ZHU WX, THORNBY JI, O'NEILL PG, ROBERTS R, 1988b. Time-course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol 254: H102-H114.
8. BOLLI R, ZUGHAIB M, LI X-Y, TANG X-L, SUN J-Z, TRIANA JF, MCCAY PB, 1995. Recurrent ischemia in the canine heart causes recurrent bursts of free radical production that have a cumulative effect on contractile function: A pathophysiological basis for chronic myocardial "stunning". J Clin Invest 96: 1066-1084.
9. BRAUNWALD E, KLONER RA, 1982. The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 66: 1146-1149.
10. BUNCH FT, THORNTON J, DOWNEY JM, 1991. Adenosine, an endogenous protectant against staccato ischemia. (Abstract) Circulation 84: II-306.
11. COBB FR, BACH RJ, GREENFIEL JC, 1974. Regional myocardial blood flow in awake dogs. J Clin Invest 53: 1618-1625.
12. COHEN MV, DOWNEY JM, 1990. Myocardial stunning in dogs: Preconditioning effect and influence of coronary collateral flow. Am Heart J 120: 282-291.
13. COHN PF, 1985. Silent myocardial ischemia: classification, prevalence, and prognosis. Am J Med 79 [Suppl. 3A]: 2-12.
14. CROTTOGINI AJ, DEPAOLI JR, BARRA JG, FISCHER EC, CHATRUC MR, PICHEL RH, DE LA FUENTE L, 1985. The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogs. Am Heart 7110: 753-760.
15. DEANFIELD JE, SELWYN AP, CHIERCHIA S, MASERI A, RIBEIRO P, KRIKLER S, MORGAN M, 1983. Myocardial ischemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet 2: 753-758.
16. DUNCKER DJ, SAXENA PR, VERDOUW PD, 1988. Systemic haemodynamics of dihydropyridine derivatives in conscious pigs with or without propranolol. Eur J Pharmacol 157: 401-409.
17. ECKSTEIN RW, 1954. Coronary interarterial anastomoses in young pigs and mongrel dogs. Circ Res 2: 460-465.
18. EHRING T, BOEHM M, HEUSCH G, 1992. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia. J Cardiovasc Pharmacol 20: 63-74.
19. FUSTER V, BADIMON L, COHEN M, AMBROSE JA, BADIMON JJ, CHESEBRO J, 1988. Insights into the pathogenesis of acute ischemic syndromes. Circulation 77: 1213-1220.
20. GROSS GJ, PIEPER GM, 1992. Beneficial actions of amlodipine in the multiple-stunned canine myocardium. Cardiovasc Drugs Ther 6: 67-75.
21. GRUM CM, GALLAGHER KP, KIRSH MM, SCHLAFER M, 1989. Absence of detectable xanthine oxidase in human myocardium. J Mol Cell Cardiol 21: 263-267.
22. HERBACZYNSKA-CEDRO K, GORDON-MAJSZAK W, 1990. Nisoldipine inhibits lipid peroxidation induced by coronary occlusion in pig myocardium. Cardiovasc Res 24: 683-687.
23. HOFFMEISTER HM, MAUSER M, SCHAPER W, 1986. Repeated episodes of regional myocardial ischemia: Effect on local function and high energy phosphate levels. Basic Res Cardial 81: 361-372.
24. JUGDUTT BI, 1985. Different relations between infarct size and occluded bed size in barbiturate-anesthetized versus conscious dogs. J Am Coll Cardiol 6: 1035-1046.
25. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79: 950-961.
26. LAMPING KA, GROSS GJ, 1985. Improved recovery of myocardial segment function following a short coronary occlusion in dogs in nicorandil, a potential new antianginal agent, and nifedipine. J Cardiovasc Pharmacol 7: 158-166.
27. LAXSON DD, HOMANS DC, DAI X-Z, SUBLETT E, BACHE RJ, 1989. Oxygen consumption and coronary reactivity in postischemic myocardium. Circ Res 64: 9-20.
28. LI X-Y MCCAY PB, ZUGHAIB M, JEROUDI MO, TRIANA JF, BOLLI R, 1993. Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest 92: 1025-1041.
29. MANDERS WT, VATNER SF, 1976. Effects of sodium pentobarbital anesthesia on left ventricular function and distribution of cardiac output in dogs, with particular reference to the mechanism for tachycardia. Circ Res 39: 512-517.
30. 19F NMR spectroscopy in intact ferret hearts. Proc Natl Acad Sci USA 84: 6005-6009.
31. MUXFELDT M, SCHAPER W, 1987. The activity of xanthine oxidase in hearts of pigs, guinea pigs, rats, and humans. Basic Res Cardial 82: 486-492.
32. NAYLER WJ, BUCKLEY DJ, LEONG J, 1990. Calcium antagonists and the "stunned" myocardium. Cardioscience 1: 61-64.
33. NAYLER WG, 1992. The role of oxygen radicals during reperfusion. J Cardiovasc Pharmacol 20 [Suppl. 5]: S14-S17.
34. NING X-H, ZWENG TN, GALLAGHER KP, 1990. Ejection-and isovolumic contration-phase wall thickening in nonischemic myocardium during coronary occlusion. Am J Physiol 258: H490-H499.
35. PODZUWEIT T, BRAUN W, MULLER A, SCHAPER W, 1987. Arrhythmias and infarction in the ischemic pig heart are not mediated by xanthine oxidase-derived free oxygen radicals. Basic Res Cardiol 82: 493-505.
36. PRZYKLENK K, GHAFARI GB, EITZMAN DT, KLONER RA, 1989. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic "stunned" myocardium. J Am Coll Cardiol 13: 1176-1183.
37. PRZYKLENK K, KLONER RA, 1988. Effect of verapamil on postischemic "stunned" myocardium: Importance of the timing of treatment. J Am Coll Cardiol 11: 614-623.
38. ROTH DM, MARUOKA Y, ROGERS J, WHITE FC, LONGHURT JC, BLOOR CM, 1987. Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium. Am J Physiol 253: H1279-H1288.
39. SAS INSTITUTE, 1988. SAS/STAT User's Guide, Release of 6.03 Edition. Cary, NC. SAS Institute, 675-712.
40. SCHAPER W, GORGE G, WINKLER B, SCHAFER J, 1988. The collateral circulation of the heart. Prog Cardiovasc Dis 31: 57-77.
41. SCOGNAMIGLIO R, PONCHIA A, FASOLI G, MIRAGLIA G, DALLA-VOLTA S, 1991. Exercise-induced left ventricular dysfunction in coronary heart disease. A model for studying the stunned myocardium in man. Eur Heart 712 [Suppl. G]: 16-19.
42. SEKILI S, MCCAY PB, LI X-Y ZUGHAIB M, SUN J-Z TANG X-L, THORNBY JI, BOLLI R, 1993. Direct evidence that the hydroxyl radical plays a pathogenetic role in myocardial "stunning" in the conscious dog and that stunning can be markedly attenuated without subsequent adverse effect. Circ Res 73: 705-723.
43. SHEIBAN I, TONNI S, BENUSSI P, MARINI A, TREVI GP, 1993. Left ventricular dysfunction following transient ischemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischemic myocardial stunning. Eur Heart 714 [Suppl. A]: 14-21.
44. STAHL LD, AVERSANO TR, BECKER LC, 1986. Selective enhancement of function of stunned myocardium by increased flow. Circulation 74: 843-851.
45. STEENBERGEN C, MURPHY E, LEVY L, LONDON RE, 1987. Elevation in cytosolic free calcium concentration early in myocardial ischemia in perfused rat hearts. Circ Res 60: 700-707.
46. SUGAWARA H, TOBISE K, ONODERA S, 1994. Absence of antioxidant effects of nifedipine and diltiazem on myocardial membrane lipid peroxidation in contrast with those of nisoldipine and propranolol. Biochem Pharmacol 47: 887-892.
47. SUN J-Z, TANG X-L, KNOWLTON AA, PARK S-W, QIU Y, BOLLI R, 1995. Late preconditioning against myocardial stunning: An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 hours after brief ischemia in conscious pigs. J Clin Invest 95: 388-403.
48. SUN J-Z, TANG X-L, PARK S-W, QIU Y, TURRENS JF, BOLLI R, 1996. Evidence for an essential role of oxygen-derived free radicals in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 97: 562-576.
49. TAYLOR AL, GOLINO P, ECKELS R, PASTOR P, BUJA LM, WILLERSON JT, 1990. Differential enhancement of post-ischemic segmental systolic thickening by diltiazem. J Am Coll Cardiol 15: 737-747.
50. TEMPLETON GH, WILDENTHAL K, WILLERSON JT, MITCHELL JH, 1975. Influence of acute myocardial depression on left ventricular stiffness and its elastic and viscous components. J Clin Invest 56: 278-285.
51. TRIANA JF, LI XY, JAMALUDDIN U, THORNBY JI, BOLLI R, 1991. Postischemic myocardial "stunning": Identification of major differences between the open-chest and the conscious dog and evaluation of the oxygen radical hypothesis in the conscious pig. Circ Res 69: 731-747.
52. VAINER SF, BRAUNWALD E, 1975. Cardiovascular control mechanisms in the conscious state. N Engl J Med 29: 970-976.
53. VAINER SF, FRANKLIN D, BRAUNWALD E, 1971a. Effects of anesthesia and sleep on circulatory response to carotid nerve stimulation. Am J Physiol 220: 1249-1255.
54. VAINER SF, HIGGINS CB, PATRICK T, FRANKLIN D, BRAUNWALD E, 1971b. Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside. J Clin Invest 50: 2585-2595.
55. VAN DER GIESSEN WJ, VAN WOERKENS LJ, DUNCKER DJ, ROELANDT JRTC, VERDOUW PD, 1989. Acute hemodynamic effects of nisoldipine and pimobendan in conscious pigs with chronic heart failure. J Cardiovasc Pharmacol 14: 653-658.
56. WALLENSTEIN S, ZUCKER CL, FLEISS JL, 1980. Some statistical methods useful in circulation research. Circ Res 47: 1-9.
57. WARLTIER DC, GROSS GJ, BROOKS HL, PREUSS KC, 1988. Improvement of postischemic, contractile function by the calcium channel blocking agent nitrendipine in conscious pigs. J Cardiovasc Pharmacol 12 [Suppl. 4]: S120-S124.
58. WEGLICKI WB, MAK IT, SIMIC MG, 1990. Mechanisms of cardiovascular drugs as antioxidants. J Mol Cell Cardiol 22: 1199-1208.
59. WHITE FC, BLOOR CM, 1981. Coronary collateral circulation in the pig: Correlation of collateral flow with coronary bed size. Basic Res Cardiol 76: 189-196.
60. WHITE FC, ROTH DM, BLOOR CM, 1986. The pig as a model for myocardial ischemia and exercise. Lab Animal Sci 36: 351-356.
61. YAO Z, CAVERO I, GROSS GJ, 1993. Activation of cardiac KATP channels: an endogenous protective mechanism during repetitive ischemia. Am J Physiol 264: H495-H504.
62. ZHU WX, MYERS ML, HARTLEY CJ, ROBERTS R, BOLLI R, 1986. Validation of a single crystal for measurement of transmural and epicardial thickening. Am J Physiol 251: H1045-H1055.